Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955032 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00955032 is a NA study that has completed, run by University of Florida. The registered enrollment target is 24 participants.
The verdict
NCT00955032, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this research study is to attempt to treat apathy in Parkinson's disease (PD) using high-frequency repetitive transcranial magnetic stimulation (rTMS) of the brain and to investigate the patterns of brain activation that may be involved in apathy. It is hypothesized that high-frequency rTMS of the left mid-dorsolateral frontal cortex will improve apathy in PD.
Interventions
- DEVICE Sham Repetitive Transcranial Magnetic Stimulation
- DEVICE High-Frequency Repetitive Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00955032
The ClinicalTrials.gov registry entry for NCT00955032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Repetitive Transcranial Magnetic Stimulation is the first listed.
NCT00955032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00955032 about?
NCT00955032 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease". The purpose of this research study is to attempt to treat apathy in Parkinson's disease (PD) using high-frequency repetitive transcranial magnetic stimulation (rTMS) of the brain and to investigate the patterns of brain activation that may be involved in apathy. It is hypothesized that high-frequenc...
What is the current status of trial NCT00955032?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2007-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00955032?
The interventions under investigation include: Sham Repetitive Transcranial Magnetic Stimulation (DEVICE), High-Frequency Repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00955032?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.